New Zealand markets open in 8 hours 16 minutes

Roivant Sciences Ltd. (ROIV)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.30+0.50 (+8.62%)
At close: 04:00PM EST
6.50 +0.20 (+3.17%)
Pre-market: 07:32AM EST

Roivant Sciences Ltd.

11-12 St. James’s Square
Suite 1, 3rd Floor
London SW1Y 4LB
United Kingdom
44 2074 003 347

Full-time employees863

Key executives

NameTitlePayExercisedYear born
Mr. Vivek RamaswamyFounder & Chairman1.26MN/A1985
Mr. Matthew GlineCEO & Director1.45MN/A1984
Dr. Eric Venker M.D., Pharm.D.Pres & COO981.38kN/A1987
Dr. Mayukh Sukhatme M.D.Pres & Chief Investment Officer910.19kN/A1976
Mr. Richard PulikChief Financial OfficerN/AN/A1979
Ms. Rakhi KumarChief Accounting OfficerN/AN/A1980
Dr. Huafeng Xu Ph.D.Chief Technology OfficerN/AN/AN/A
Mr. Josh ChenGen. CounselN/AN/AN/A
Ms. Kelly GraffHead of PeopleN/AN/AN/A
Ms. Marianne L. RomeoHead of Global Transactions & Risk ManagementN/AN/A1968
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Corporate governance

Roivant Sciences Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.